SciELO - Scientific Electronic Library Online

 
vol.40 número3Absceso anorrectal por ingesta de cuerpo extraño: reporte de casoPólipo fibrovascular esofágico distal: presentación de caso índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista colombiana de Gastroenterología

versión impresa ISSN 0120-9957versión On-line ISSN 2500-7440

Rev. colomb. Gastroenterol. vol.40 no.3 Bogotá jul./set. 2025  Epub 12-Nov-2025

https://doi.org/10.22516/25007440.1280 

Report of cases

Cholestatic Acute Hepatitis as an Unusual Manifestation of Syphilis in an Immunocompetent Patient: A Case Report

Carlos Andrés Marín-Hoyos1 
http://orcid.org/0000-0001-6227-9105

Karen Juliana Moreno2  * 
http://orcid.org/0000-0002-7344-8602

Jhonattan Fabian Morales-Giraldo3 
http://orcid.org/0000-0002-1668-3585

Raúl Vallejo-Serna4 
http://orcid.org/0000-0002-0692-5077

Diego Mauricio Gómez-Ramírez5 
http://orcid.org/0000-0002-3971-8082

1Medical Student, Universidad Libre. Cali, Colombia.

2Resident Physician, Universidad del Valle. Cali, Colombia.

3Internal Medicine Physician, Universidad del Valle, Hospital Universitario del Valle. Cali, Colombia.

4Internal Medicine Physician, Universidad del Valle. Cali, Colombia.

5Gastroenterologist and Hepatologist, Clínica Farallones, Clínica Nuestra Cali, and Clínica Imbanaco. Cali, Colombia.


Abstract

Acute hepatitis is among the most underdiagnosed clinical presentations of syphilis. Its incidence is higher in individuals living with human immunodeficiency virus (HIV) and less frequently reported in immunocompetent patients. Diagnosis should be suspected in the presence of risk factors and typical clinical manifestations of the infection. Timely treatment is crucial for disease control and the prevention of complications. We report the case of a young immunocompetent adult who developed cholestatic acute hepatitis as a manifestation of secondary syphilis.

Keywords: Hepatitis; syphilis

Resumen

La hepatitis aguda es una de las presentaciones clínicas de sífilis más subdiagnosticada. Su incidencia es mayor en personas que viven con virus de inmunodeficiencia humana (VIH), y es menos reportada en pacientes inmunocompetentes. El diagnóstico se debe sospechar en presencia de factores de riesgo y manifestaciones clínicas típicas de la infección. El tratamiento oportuno es clave para el control de la enfermedad y la prevención de complicaciones. Se presenta el caso de un adulto joven inmunocompetente que desarrolló hepatitis aguda colestásica como manifestación de sífilis secundaria.

Palabras clave: Hepatitis; sífilis

Introduction

Hepatitis is a condition characterized by an inflammatory process that can be caused by infections, drug toxicity, autoimmune and metabolic diseases, and various genetic defects. The most common etiologies of acute hepatitis are alcohol and hepatotropic viruses; however, other, much less common infections, such as syphilis, can cause acute hepatitis due to their capacity for multi-organ involvement1. Syphilitic hepatitis is a rarely diagnosed entity with an incidence ranging from 0.25% to 3%2,3; however, it can reach up to 41% in patients coinfected with the human immunodeficiency virus (HIV)4. It is characterized by a cholestatic pattern with a predominant elevation of alkaline phosphatase and a mild increase in bilirubin and transaminases5.

Case Presentation

A 23-year-old male patient presented to the emergency department with a one-month history of generalized, intermittent, colicky abdominal pain, associated with the appearance of a non-pruritic maculopapular rash on the upper limbs, thorax, and palmoplantar areas. His medical history revealed no relevant pathologies or previous transfusions; he denied the use of inhaled, injectable, or oral psychoactive substances; no use of hepatotoxic substances or travel in the last three months was found; however, he reported risky sexual activity (unprotected sexual intercourse with more than two partners in the last year). Physical examination revealed a generalized maculopapular rash on the upper limbs, thorax, and palmoplantar areas, associated with conjunctival and mucocutaneous jaundice.

Diagnostic tests showed altered liver function tests, with the R factor demonstrating a predominant cholestatic pattern, along with aspartate aminotransferase (AST): 207 UI/L, alanine aminotransferase (ALT): 358 UI/L, γ-glutamyl transferase (GGT): 540 UI/L, alkaline phosphatase (ALP): 1328 UI/L, total bilirubin: 2.3 mg/dL and direct bilirubin: 2.06. The complete blood count, coagulation tests, and the rest of the basic biochemistry were normal. Imaging tests were ordered to rule out causes of biliary obstruction. An abdominal ultrasound showed mild hepatomegaly without other findings, and a magnetic resonance cholangiopancreatography corroborated the ultrasound findings, showing no evidence of intra- or extrahepatic bile duct dilation or stones, with lymph nodes near the porta hepatis at the retroperitoneal level. Serology for hepatotropic viruses (immunoglobulin M [IgM] antibodies for hepatitis A virus, surface antigen for hepatitis B, antibodies for hepatitis C, antibodies against the surface antigen of the hepatitis B virus) and other possible viral etiologies (IgM antibodies against cytomegalovirus, IgM against Epstein-Barr virus, and fourth-generation human immunodeficiency virus [HIV] enzyme-linked immunosorbent assay [ELISA]), an autoimmunity panel (antinuclear antibodies, antimitochondrial antibodies, and anti-smooth muscle antibodies), iron profile, and ceruloplasmin were all negative. Additionally, a rapid plasma reagin (RPR) test was reactive at 1:64 dilutions, and serum total antibodies for treponema (FTA-ABS) were positive.

The diagnosis of acute syphilitic hepatitis was made based on positive syphilitic serology and elevated liver enzymes, after ruling out other causes, including viral, autoimmune, deposition, toxic, or pharmacological etiologies. Treatment was initiated with benzathine penicillin G 2,400,000 units intramuscularly in a single dose, which led to subsequent normalization of liver function tests and a decrease in non-treponemal syphilis serology (RPR) titers at the three-month follow-up.

Discussion

Acute hepatitis is one of the possible clinical manifestations of syphilis and can often be underdiagnosed and underreported6. It has been described more frequently in patients coinfected with HIV, and is less frequent and unusual in immunocompetent patients, like the one in our case4,7. It occurs more often in the early stages of infection and is detected mainly in the primary and secondary phases (88%), followed by the latent phase (7%) and the tertiary phase (6%)7. Its development occurs after the hematogenous dissemination of the spirochete, which allows it to reach different organs, including the liver, generating an inflammatory response in the hepatocytes and bile ducts6-8. In the secondary syphilis phase, the involvement is predominantly cholestatic and often coincides with fever, a typical palmoplantar rash, and even nephrotic syndrome9,10.

Diagnostic criteria were proposed in 2004 and consist of altered liver enzymes, positive serological tests for Treponema pallidum, exclusion of other causes of liver disease, and normalization of liver enzymes after appropriate antibiotic treatment8. Relevant entities for the differential diagnosis of the cholestatic pattern include choledocholithiasis, malignant biliary duct obstruction, hepatotoxicity, primary biliary cholangitis, sclerosing cholangitis, infiltrative diseases, and infections that can lead to cholestasis. Liver biopsy is not essential for diagnosis, but if performed, the described histological findings include inflammatory infiltration of the bile duct, hepatic granulomas, periportal necrosis, and endotheliitis, which are non-pathognomonic findings, except for the detection of T. pallidum with dark-field microscopy in the liver parenchyma11,12.

Although our case illustrates a typical presentation and clinical response, fulminant liver failure has been described13. The treatment for acute secondary syphilitic hepatitis is benzathine penicillin G 2,400,000 units intramuscularly in a single dose, and the outcome is excellent in most patients, who show improvement in clinical symptoms and liver biochemistry within weeks14.

Conclusions

Syphilitic hepatitis is an underdiagnosed entity that can affect both immunocompromised and immunocompetent patients. It usually presents with mild and non-specific clinical manifestations, and altered liver profile and syphilis serology are key for diagnosis. Treatment with penicillin is effective and can prevent serious complications such as acute liver failure.

Referencias

1. Al Dallal HA, Narayanan S, Alley HF, Eiswerth MJ, Arnold FW, Martin BA, et al. Case Report: Syphilitic Hepatitis-A Rare and Underrecognized Etiology of Liver Disease With Potential for Misdiagnosis. Front Med (Lausanne). 2021;8:789250. https://doi.org/10.3389/fmed.2021.789250Links ]

2. Pizzarossa AC, Rebella M. Hepatitis in patients with syphilis: an overlooked association. BMJ Case Rep. 2019;12(1):bcr-2018-226918. https://doi.org/10.1136/bcr-2018-226918Links ]

3. Adachi E, Koibuchi T, Okame M, Sato H, Kikuchi T, Koga M, et al. Liver dysfunction in patients with early syphilis: a retrospective study. J Infect Chemother. 2013;19(1):180-2. https://doi.org/10.1007/s10156-012-0440-5Links ]

4. Salado-Rasmussen K, Wessman M, Cowan SA, Gerstoft J, Katzenstein TL. Syphilitic hepatitis and neurosyphilis: an observational study of Danish HIV-infected individuals during a 13-year period. Sex Transm Infect. 2019;95(6):416-418. https://doi.org/10.1136/sextrans-2018-053921Links ]

5. Ridruejo E, Mordoh A, Herrera F, Vizzotti G, Vila M, Marciano S, et al. Severe cholestatic hepatitis as the first symptom of secondary syphilis. Dig Dis Sci. 2004;49(9):1401-4. https://doi.org/10.1023/B:DDAS.0000042237.40205.c6Links ]

6. Pereira FG, Leal MS, Meireles D, Cavadas S. Syphilitic hepatitis; a rare manifestation of a common disease. Gastroenterol Hepatol Bed Bench. 2021;14(1):77-80. [ Links ]

7. Huang J, Lin S, Wan B, Zhu Y. A Systematic Literature Review of Syphilitic Hepatitis in Adults. J Clin Transl Hepatol. 2018;6(3):306-309. https://doi.org/10.14218/JCTH.2018.00003Links ]

8. Mullick CJ, Liappis AP, Benator DA, Roberts AD, Parenti DM. Syphilitic hepatitis in HIV-infected patients: a report of 7 cases and review of the literature. Clin Infect Dis. 2004;39(1):100-5. https://doi.org/10.1086/425501Links ]

9. Lee M, Wang C, Dorer R, Taylor D. A great masquerader: acute syphilitic hepatitis. Dig Dis Sci. 2013;58(4):923-5. https://doi.org/10.1007/s10620-012-2322-1Links ]

10. Ibáñez M, Varela M, Rodríguez-Peláez M, Gómez-Durán MS, Sánchez-Pobre P, Álvarez-Sala R. Luetic hepatitis. An emerging entity. Gastroenterol Hepatol. 2009;32(8):610-3. https://doi.org/10.1016/j.gastrohep.2009.05.001Links ]

11. Huang J, Lin S, Wan B, Wang C, Li J, Zhao D. A systematic literature review of syphilitic hepatitis in adults. J Clin Transl Hepatol. 2018;6(3):306-9. https://doi.org/10.1080/07853890.2023.2239828Links ]

12. Marcos P, Eliseu L, Henrique M, Fernandes I, Martins A. Syphilitic hepatitis: Case report of an overlooked condition. Clin Case Rep. 2019;8(1):123-6. https://doi.org/10.24875/PJDV.M22000032Links ]

13. Affonso da Costa AB, Fornazari B, da Silva FPM, Lima LV, Zubaran PE, Sperandio FF. Fulminant hepatitis in a patient with secondary syphilis. Int J STD AIDS. 2018;29(13):1348-50. https://doi.org/10.1177/0956462418785257Links ]

14. Ferreira-González L, Rubín de Celis EP, Sesma P. Neurosyphilis after treatment of syphilitic hepatitis in an immunocompetent patient. Enferm Infecc Microbiol Clin. 2012;30(5):274-5. https://doi.org/10.1016/j.eimc.2012.01.015Links ]

Citation: Marín-Hoyos CA, Moreno KJ, Morales-Giraldo JF, Vallejo-Serna R, Gómez-Ramírez DM. Cholestatic Acute Hepatitis as an Unusual Manifestation of Syphilis in an Immunocompetent Patient: A Case Report. Revista. colomb. Gastroenterol. 2025;40(3):377-379. https://doi.org/10.22516/25007440.1280

Received: August 29, 2024; Accepted: December 06, 2024

*Correspondence: Karen Juliana Moreno. karenjulianamorenosoto@gmail.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License